Cargando…
Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer
Immune checkpoint blockade (ICB) therapy has achieved breakthroughs in the treatment of advanced non–small cell lung cancer (NSCLC). Nevertheless, the low response due to immuno-cold (i.e., tumors with limited tumor-infiltrating lymphocytes) tumor microenvironment (TME) largely limits the applicatio...
Autores principales: | Mao, Wenjun, Cai, Yun, Chen, Danrong, Jiang, Guanyu, Xu, Yongrui, Chen, Ruo, Wang, Fengxu, Wang, Xuehai, Zheng, Mingfeng, Zhao, Xinyuan, Mei, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675559/ https://www.ncbi.nlm.nih.gov/pubmed/35943796 http://dx.doi.org/10.1172/jci.insight.161940 |
Ejemplares similares
-
Anlotinib Induces a T Cell–Inflamed Tumor Microenvironment by Facilitating Vessel Normalization and Enhances the Efficacy of PD-1 Checkpoint Blockade in Neuroblastoma
por: Su, Yudong, et al.
Publicado: (2022) -
HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC
por: Mei, Jie, et al.
Publicado: (2022) -
Identification of adenoid subtype characterized with immune-escaped phenotype in lung squamous carcinoma based on transcriptomics
por: Mei, Jie, et al.
Publicado: (2022) -
Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis
por: Wang, Xiaokun, et al.
Publicado: (2023) -
Recurrent lung adenocarcinoma benefits from microwave ablation following multidisciplinary treatments: A case with long-term survival
por: Jiang, Guanyu, et al.
Publicado: (2023)